Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-09-25 07:00 |
Valneva annonce un nouveau contrat d’une valeur minimale de $32 millions avec l…
|
French | 144.6 KB | ||
| 2023-09-25 07:00 |
Valneva Announces New IXIARO® Supply Contract with the U.S. Government Worth a …
|
English | 109.8 KB | ||
| 2023-09-21 07:00 |
Valneva Reports Half Year 2023 Financial Results and Provides Corporate Updates
|
English | 327.1 KB | ||
| 2023-09-21 07:00 |
Valneva publie ses résultats financiers du premier semestre 2023 et fait un poi…
|
French | 345.4 KB | ||
| 2023-09-07 07:00 |
Valneva et Pfizer annoncent des données positives de Phase 2 chez les enfants e…
|
French | 233.9 KB | ||
| 2023-09-07 07:00 |
Valneva and Pfizer Report Positive Pediatric and Adolescent Phase 2 Booster Re…
|
English | 232.2 KB | ||
| 2023-09-06 08:30 |
VALNEVA Déclaration d’actions et de droits de vote : 31 août 2023
|
French | 13.8 KB | ||
| 2023-09-06 08:30 |
VALNEVA Declaration of shares and voting rights: August 31, 2023
|
English | 14.0 KB | ||
| 2023-08-31 19:00 |
Valneva participera à différentes conférences investisseurs aux Etats-Unis et e…
|
French | 146.8 KB | ||
| 2023-08-31 19:00 |
Valneva to Participate in Investor Conferences in the United States and Europe …
|
English | 110.0 KB | ||
| 2023-08-29 07:00 |
Santé Canada juge recevable le dossier de demande d’autorisation de mise sur le…
|
French | 229.0 KB | ||
| 2023-08-29 07:00 |
Health Canada Accepts Valneva’s Chikungunya Vaccine License Application for Rev…
|
English | 205.2 KB | ||
| 2023-08-28 07:00 |
Valneva annonce de premières données positives de Phase 3 concernant l’innocuit…
|
French | 215.4 KB | ||
| 2023-08-17 07:00 |
Valneva annonce l’augmentation du volume de son accord de financement par empru…
|
French | 181.1 KB | ||
| 2023-08-17 07:00 |
Valneva Announces Extension of Existing Loan Agreement
|
English | 111.1 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
